These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7476304

  • 1. Insulin-like growth factors (IGFs) and IGF-I treatment in the adolescent with insulin-dependent diabetes mellitus.
    Dunger DB, Cheetham TD, Crowne EC.
    Metabolism; 1995 Oct; 44(10 Suppl 4):119-23. PubMed ID: 7476304
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. IGF-I and diabetes in adolescence.
    Dunger DB, Acerini CL.
    Diabetes Metab; 1998 Apr; 24(2):101-7. PubMed ID: 9592633
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Growth hormone insulin-like growth factor I axis in insulin-dependent diabetes mellitus.
    Dunger DB, Cheetham TD.
    Horm Res; 1996 Jul; 46(1):2-6. PubMed ID: 8854134
    [Abstract] [Full Text] [Related]

  • 6. Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetes.
    Dunger DB, Edge JA, Pal R, Taylor AM, Holly JM, Matthews DR.
    Acta Paediatr Scand Suppl; 1991 Jul; 377():69-77; discussion 78. PubMed ID: 1723835
    [Abstract] [Full Text] [Related]

  • 7. Recombinant IGF-I therapy in insulin-dependent diabetes mellitus.
    Savage MO, Dunger DB.
    Diabetes Metab; 1996 Jul; 22(4):257-60. PubMed ID: 8767172
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus.
    Crowne EC, Samra JS, Cheetham T, Acerini CL, Watts A, Holly JM, Dunger DB.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3686-91. PubMed ID: 11502796
    [Abstract] [Full Text] [Related]

  • 13. Childhood and adolescent diabetes.
    Dunger DB, Regan FM, Acerini CL.
    Endocr Dev; 2005 Aug; 9():107-120. PubMed ID: 15879693
    [Abstract] [Full Text] [Related]

  • 14. Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM.
    Hanaire-Broutin H, Sallerin-Caute B, Poncet MF, Tauber M, Bastide R, Chalé JJ, Rosenfeld R, Tauber JP.
    Diabetologia; 1996 Dec; 39(12):1498-504. PubMed ID: 8960832
    [Abstract] [Full Text] [Related]

  • 15. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C, Woods KA, Miraki-Moud F, Hindmarsh PC, Clark AJ, Hansson Y, Johnston A, Baxter RC, Savage MO.
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [Abstract] [Full Text] [Related]

  • 16. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
    Acerini CL, Harris DA, Matyka KA, Watts AP, Umpleby AM, Russell-Jones DL, Dunger DB.
    Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
    [Abstract] [Full Text] [Related]

  • 17. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia.
    Katz LE, Liu F, Baker B, Agus MS, Nunn SE, Hintz RL, Cohen P.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1141-6. PubMed ID: 8772589
    [Abstract] [Full Text] [Related]

  • 18. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
    Saukkonen T, Amin R, Williams RM, Fox C, Yuen KC, White MA, Umpleby AM, Acerini CL, Dunger DB.
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
    [Abstract] [Full Text] [Related]

  • 19. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J, Urban M, Głowińska B, Urban B.
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [Abstract] [Full Text] [Related]

  • 20. Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization.
    Hanaire-Broutin H, Sallerin-Caute B, Poncet MF, Tauber M, Bastide R, Rosenfeld R, Tauber JP.
    Diabetes Metab; 1996 Jul; 22(4):245-50. PubMed ID: 8767170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.